Home › Core › ISCC-IDs › 28C9rCzDhSDuM

View ISCC-ID

Core Data

28C9rCzDhSDuM
ISCC-ID - digital asset identifier
CChywQndtmeU6-CT5CVyrjhRh6C-CDDPASdDSor6u-CRZ62R9E3129b
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

elevated hepatocyte growth factor expression as an autocrine cmet activation mechanism in acquired resistance to sorafenib in he

Ledger Reference

coblo
Source Ledger/Blockchain
6987
N-th ISCC Decleration on source ledger
2bc83303297722a0f6abe277b343e4f101f8e218005ea4d207f384908d9886d4
Hash of block that includes the ISCC-DECLARATION
9e8580da9025e6e174938615b0c743ef40567b92f65a96323a429a482a715dc4
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Zeynep Firtina Karagonlar", "@type": "Person"}, {"name": "Dogukan Koc", "@type": "Person"}, {"name": "Evin Iscan", "@type": "Person"}, {"name": "Esra Erdal", "@type": "Person"}, {"name": "Ne\u015fe Atabey", "@type": "Person"}], "license": "cc-by-nc-nd", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4832867?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Wiley-Blackwell", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1111/cas.12891", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CChywQndtmeU6-CT5CVyrjhRh6C-CDDPASdDSor6u-CRZ62R9E3129b", "propertyID": "ISCC"}], "datePublished": "2016-02-23"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close